Biofrontera (BFRI) News Today $0.73 +0.03 (+4.26%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Biofrontera Inc. Reports Q3 2024 Earnings GrowthNovember 16 at 2:52 AM | markets.businessinsider.comBiofrontera Inc. (NASDAQ:BFRI) Q3 2024 Earnings Call TranscriptNovember 16 at 2:52 AM | msn.comBenchmark Co. Remains a Buy on Biofrontera (BFRI)November 16 at 2:52 AM | markets.businessinsider.comBiofrontera Inc (BFRI) Q3 2024 Earnings Call Highlights: Strategic Advancements Amidst Revenue ...November 15 at 2:30 AM | finance.yahoo.comBiofrontera Inc. Reports Third Quarter and Nine-Month 2024 Financial Results and Provides Business UpdateNovember 13, 2024 | globenewswire.comBiofrontera (BFRI) Set to Announce Earnings on WednesdayNovember 11, 2024 | americanbankingnews.comBiofrontera Announces Promising Phase 3 Study ResultsOctober 31, 2024 | markets.businessinsider.comBiofrontera Inc. Announces Highly Significant Results In Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) Regarding The Treatment Of Superficial Basal Cell Carcinoma (sBCC)October 31, 2024 | globenewswire.comBiofrontera Inc. Announces Database Lock Of Phase 3 Study Of Ameluz®-Photodynamic Therapy (PDT) In The Treatment Of Superficial Basal Cell Carcinoma (sBCC)October 14, 2024 | globenewswire.comBiofrontera Inc (BFRI) Q2 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic ...October 9, 2024 | finance.yahoo.comBiofrontera: FDA Approves SNDA To Increase Maximally Approved Dosage Of Ameluz - Quick FactsOctober 8, 2024 | markets.businessinsider.comFDA Approves Use of Up To Three Tubes of Biofrontera Inc.’s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One TreatmentOctober 8, 2024 | markets.businessinsider.comFDA Approves Use of Up To Three Tubes of Biofrontera Inc.'s Ameluz (aminolevulinic acid HCI) Topical Gel, 10% In One TreatmentOctober 7, 2024 | globenewswire.comBiofrontera Second Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagAugust 18, 2024 | finance.yahoo.comBiofrontera Inc. Reports Second Quarter 2024 Financial Results and Provides a Business UpdateAugust 14, 2024 | globenewswire.comBiofrontera earnings: here's what Wall Street expectsAugust 14, 2024 | markets.businessinsider.comBiofrontera Announces the Launch of a New, FDA-Approved Red Light Source, the RhodoLED® XL LampJune 24, 2024 | globenewswire.comBiofrontera GAAP EPS of -$2.88, revenue of $7.9MMay 15, 2024 | msn.com3 Mind-Blowing Stocks That Could Turn $1,000 Into $1 MillionMarch 24, 2024 | investorplace.comBiofrontera Inc. (BFRI) Q4 2023 Earnings Call TranscriptMarch 20, 2024 | seekingalpha.comBiofrontera Inc. (NASDAQ:BFRI) Q4 2023 Earnings Call TranscriptMarch 19, 2024 | finance.yahoo.comBiofrontera GAAP EPS of $1.65 beats by $2.79, revenue of $10.6M misses by $1.21MMarch 18, 2024 | msn.comBiofrontera stock soars on announcing private placement of up to $16MFebruary 20, 2024 | msn.comTrading was temporarily halted for "BFRI" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 10:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 10:02 AM. February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:02 AM with a stated reason of "LULD pause."February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 20, 2024 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:02 AM with a stated reason of "LULD pause." Trading set to resume at 09:02 AM. February 20, 2024 | marketbeat.comBiofrontera Inc. Announces Restructuring of Supply Agreement with Biofrontera AGFebruary 20, 2024 | finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI): Is Breakeven Near?January 31, 2024 | finance.yahoo.comBiofrontera sees 19% growth in prelim FY 2023 revenueJanuary 11, 2024 | msn.comBiofrontera Inc. (BFRI) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?November 22, 2023 | finance.yahoo.comBiofrontera Inc. (NASDAQ:BFRI) Q3 2023 Earnings Call TranscriptNovember 11, 2023 | finance.yahoo.comBenign Growth For Biofrontera Inc. (NASDAQ:BFRI) Underpins Stock's 50% PlummetNovember 11, 2023 | finance.yahoo.comBiofrontera Inc. Reports Third Quarter 2023 Financial Results and Provides a Business UpdateNovember 9, 2023 | finance.yahoo.comBiofrontera Inc. (BFRI) Upgraded to Buy: Here's What You Should KnowNovember 9, 2023 | finance.yahoo.comBiofrontera Inc. to Report Third Quarter 2023 Financial Results on November 9 and Hold Conference Call on November 10November 3, 2023 | finance.yahoo.comTrading was temporarily halted for "BFRI" at 02:11 PM with a stated reason of "LULD pause."November 1, 2023 | marketbeat.comBiofrontera Inc. Announces $4.5 Million Registered Direct Offering Priced At-the-market Under NASDAQ RulesOctober 31, 2023 | finance.yahoo.comTrading was temporarily halted for "BFRI" at 10:10 AM with a stated reason of "LULD pause."October 24, 2023 | marketbeat.comBiofrontera Inc. (BFRI) Stock Price, News, Quote & History - Yahoo FinanceOctober 21, 2023 | ca.finance.yahoo.comTrading was temporarily halted for "BFRI" at 02:10 PM with a stated reason of "LULD pause."October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 01:10 PM with a stated reason of "LULD pause." Trading set to resume at 01:10 PM. October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 10:10 AM with a stated reason of "LULD pause."October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 10:10 AM with a stated reason of "LULD pause."October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:10 AM with a stated reason of "LULD pause." Trading set to resume at 09:10 AM. October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 09:10 AM with a stated reason of "LULD pause."October 19, 2023 | marketbeat.comTrading was temporarily halted for "BFRI" at 03:10 PM with a stated reason of "LULD pause."October 18, 2023 | marketbeat.com Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Buffett’s Selling Out: Is Your 401(k) About to Get Wiped Out? (Ad)Let me share something important with you. Just a few weeks ago, Warren Buffett unloaded $932 million worth of bank stocks. He didn't do it on a whim—he knows something big is coming. The question is: Why aren't you taking action, too? Click Here For Your Free Guide BFRI Media Mentions By Week BFRI Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BFRI News Sentiment▼-0.010.56▲Average Medical News Sentiment BFRI News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BFRI Articles This Week▼90▲BFRI Articles Average Week Get Biofrontera News Delivered to You Automatically Sign up to receive the latest news and ratings for BFRI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies BFRG News Today TNXP News Today MRNS News Today CVKD News Today NNVC News Today CARA News Today APRE News Today FNCH News Today COCP News Today TXMD News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:BFRI) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Biofrontera Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Biofrontera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
